Pharma-Bio Serv (PBSV) EBT Margin (2010 - 2026)
Pharma-Bio Serv posted quarterly EBT Margin of 1.59% for Q1 2026, up 120.0% year-on-year from 0.72% in Q1 2025, and up 703.46% on a QoQ basis from 0.2% in Q4 2025.
Pharma-Bio Serv (PBSV) has 16 years of EBT Margin data on file, last reported at 1.59% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 120.0% year-over-year to 1.59%; the trailing twelve-month figure through Jan 2026 stood at 0.76% (up 432.0% YoY), and the FY2025 full-year result was 1.05%, up 690.0% from the prior year.
- EBT Margin for Q1 2026 stood at 1.59%, up from 0.2% in the prior quarter.
- Across five years, EBT Margin topped out at 13.57% in Q1 2023 and bottomed at 12.0% in Q3 2024.
- The 5-year median for EBT Margin is 1.59% (2026), against an average of 1.54%.
- Peak annual rise in EBT Margin reached 9068 bps in 2022, while the deepest fall reached 3976 bps in 2022.
- A 5-year view of EBT Margin shows it stood at 4.98% in 2022, then sank by 127 bps to 1.33% in 2023, then soared by 52 bps to 0.64% in 2024, then jumped by 131 bps to 0.2% in 2025, then jumped by 703 bps to 1.59% in 2026.
- The last three EBT Margin figures came in at 1.59% (Q1 2026), 0.2% (Q4 2025), and 10.65% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 37.99% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 2.29% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 26.06% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 19.72% |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 22.10% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 19.06% |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -8.52% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 1.54% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 5.46% |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | 1.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 1.59% |
| Oct 31, 2025 | 0.20% |
| Jul 31, 2025 | -10.65% |
| Apr 30, 2025 | 4.17% |
| Jan 31, 2025 | 0.39% |
| Oct 31, 2024 | -0.64% |
| Jul 31, 2024 | -12.00% |
| Apr 30, 2024 | -8.10% |
| Jan 31, 2024 | -10.83% |
| Oct 31, 2023 | -1.33% |
| Jul 31, 2023 | 12.83% |
| Apr 30, 2023 | 12.55% |
| Jan 31, 2023 | 13.57% |
| Oct 31, 2022 | 4.98% |
| Jul 31, 2022 | 6.62% |
| Apr 30, 2022 | 5.74% |
| Jan 31, 2022 | 7.10% |
| Oct 31, 2021 | -85.70% |
| Jul 31, 2021 | 46.38% |
| Apr 30, 2021 | 5.67% |
| Jan 31, 2021 | 7.16% |
| Oct 31, 2020 | 3.03% |
| Jul 31, 2020 | 12.53% |
| Apr 30, 2020 | 13.62% |
| Jan 31, 2020 | 12.62% |
| Oct 31, 2019 | 10.03% |
| Jul 31, 2019 | 8.91% |
| Apr 30, 2019 | 15.20% |
| Jan 31, 2019 | 11.26% |
| Oct 31, 2018 | 9.32% |
| Jul 31, 2018 | 16.73% |
| Apr 30, 2018 | -0.23% |
| Jan 31, 2018 | 6.14% |
| Oct 31, 2017 | 6.72% |
| Jul 31, 2017 | -4.06% |
| Apr 30, 2017 | -8.23% |
| Jan 31, 2017 | -9.40% |
| Oct 31, 2016 | -11.04% |
| Jul 31, 2016 | -2.42% |
| Apr 30, 2016 | 0.87% |
| Jan 31, 2016 | 7.78% |
| Oct 31, 2015 | 9.85% |
| Jul 31, 2015 | 8.01% |
| Apr 30, 2013 | 21.18% |
| Jan 31, 2013 | 16.86% |
| Oct 31, 2012 | 17.05% |
| Jul 31, 2012 | 20.55% |
| Apr 30, 2012 | 20.25% |
| Jan 31, 2012 | 21.44% |
| Oct 31, 2011 | 16.57% |
| Jul 31, 2011 | 21.21% |
| Apr 30, 2011 | 16.11% |
| Jan 31, 2011 | 14.50% |
| Oct 31, 2010 | 9.03% |
| Jul 31, 2010 | 7.05% |